Ansell Ltd
ASX:ANN
Ansell Ltd
ASX:ANN
Price:
29.64
AUD
-0.9%
Market Closed
Market Cap:
AU$4.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ansell Ltd
ASX:ANN
|
AU |
Multiples-Based Value
The
Multiples-Based Value for
Ansell Ltd (ANN)
under the Base Case is
33.73
AUD.
Compared with the current market price of 29.64 AUD, the stock appears
Undervalued by 12%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ANN
Multiples-Based Value
Base Case
33.73
AUD
Undervaluation 12%
Multiples Across Competitors
ANN Competitors Multiples
Ansell Ltd Competitors
Ansell Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Ansell Ltd
ASX:ANN
|
4.3B AUD | 1.5 | 22.1 | 11.4 | 11.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY | 10.7 | 39.1 | 28.4 | 34.1 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.8B CHF | 3.6 | 37.9 | 14.6 | 28.3 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
36B USD | 0 | 0 | 0 | 0 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
98B DKK | 3.4 | 24.1 | 12.7 | 15.2 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.6B USD | 3.1 | 30.8 | 13.2 | 18.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
954.9B JPY | 7.4 | 54 | 25.6 | 34.8 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.4B GBP | 2.4 | 33.3 | 11.6 | 18.2 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD | 1.1 | -16.2 | 17.2 | 55.8 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
38B CNY | 3.9 | 22.3 | 33.2 | 33.2 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
37.6B CNY | 8.3 | 22.8 | 20.5 | 20.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
